Monkeypox Concept(BK4583),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

BK4583 Monkeypox Concept

Trading 06-09 10:41:45 EDT

1,783.56

-23.83

-1.32%

High1,817.84	Low1,755.94	Vol4.21M
Open1,815.23	D1 Closing1,807.39	Amplitude3.42%
Mkt Cap0.00	Tradable Cap0.00	Total Shares0.00
T/O274.46M	T/O Rate--	Tradable Shares0.00
P/B4.348478	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"BK4583","market":"US","secType":"PLATE","nameCN":"Monkeypox Concept","latestPrice":1783.5608,"timestamp":1781016105020,"preClose":1807.3939,"halted":0,"volume":4212811,"delay":0,"changeRate":-0.013186,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Trading","change":-23.83313,"latestTime":"06-09 10:41:45 EDT","open":1815.2322,"high":1817.8376,"low":1755.9364,"amount":274464403.503029,"amplitude":0.034249,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1781035200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":4.348478,"peRate":20.861295,"turnoverRate":0.001559,"increases":4,"decrements":5,"flats":1,"marketCap":197753534805,"floatMarketCap":196895986883.25},"requestUrl":"/m/hq/s/BK4583/wiki","defaultTab":"wiki","newsList":[{"id":"2642324467","title":"Wall Street Analysts Are Bullish on Top Healthcare Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=2642324467","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642324467?lang=en_us&edition=fundamental","pubTime":"2026-06-09 19:50","pubTimestamp":1781005811,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Gilead Sciences (GILD), Jazz Pharmaceuticals (JAZZ) ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-213?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-213?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00B19Z3581.USD","IE00B3T34201.USD","LU0965509010.AUD","LU1066051498.USD","LU1023059063.AUD","LU1066053197.SGD","LU1585245621.USD","LU1934455277.USD","BK4533","LU0965509101.SGD","LU0154245756.USD","LU0823416689.USD","SG9999015978.USD","IE00B19Z3B42.SGD","LU1430594728.SGD","BK4532","LU1061106388.HKD","LU0114720955.EUR","LU1037948541.HKD","IE00BKVL7J92.USD","IE00BN0W2T93.GBP","LU0058720904.USD","LU1934455194.USD","LU0234570918.USD","LU0965509283.SGD","SG9999015945.SGD","SG9999015986.USD","LU1674673428.USD","IE00BZ1G4Q59.USD","BK4568","LU0861579265.USD","IE00BN0W2W23.USD","LU0889565916.HKD","LU0320765992.SGD","LU1571399168.USD","BK4578","LU1839511570.USD","LU1057294990.SGD","LU2089984988.USD","LU0154245673.USD","BK4007","SG9999015952.SGD","IE00BSNM7G36.USD","JAZZ","LU0109394709.USD","BK4550","IE0002270589.USD","BK4588","LU0965508806.USD","LU2468319806.SGD","LU1037948897.HKD","IE00B7SZLL34.SGD","LU0882574055.USD","LU0289739699.SGD","LU1778281490.HKD","LU1934455863.HKD","LU2087621335.USD","BK4139","IE00BN0W2V16.EUR","BK4583","LU2112291526.USD","LU2324357040.USD","GILD","LU1674673691.USD","BK4585","BK4566","LU0122379950.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1171444260","title":"Merck and Gilead's Combined HIV Drug Meets Primary Goals in Late-Stage Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=1171444260","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1171444260?lang=en_us&edition=fundamental","pubTime":"2026-06-09 15:04","pubTimestamp":1780988676,"startTime":"0","endTime":"0","summary":"Preliminary results from two Phase 3 trials for a combination tablet containing Merck's (MRK.US) drug islatravir and Gilead Sciences' (GILD.US) drug lenacapavir have successfully met their primary...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014567.USD","LU0823416689.USD","LU0868494708.USD","IE0002141913.USD","LU1066051498.USD","SG9999001176.SGD","IE00B4R5TH58.HKD","LU0320765489.SGD","IE00B3T34201.USD","LU2023250504.SGD","LU0889565916.HKD","GILD","IE000M9KFDE8.USD","SG9999015358.SGD","BK4550","LU0320765992.SGD","LU1941712264.USD","IE00BLSP4239.USD","LU1116320737.USD","LU2357627491.SGD","IE0002270589.USD","BK4007","IE00BN8TJ469.HKD","LU0965509101.SGD","IE00B1BXHZ80.USD","LU1839511570.USD","LU0098860793.USD","LU2106854487.HKD","LU0868494617.USD","BK4583","LU0965508806.USD","IE00B19Z3581.USD","LU0985320562.USD","SG9999014542.SGD","SG9999015978.USD","LU2461242641.AUD","LU0289739699.SGD","LU0882574055.USD","SG9999015986.USD","SG9999001176.USD","BK4568","LU1023059063.AUD","LU2361045086.USD","LU1974910355.USD","LU1989772923.USD","LU1989772840.SGD","LU0070302665.USD","LU1941712348.USD","LU0265550946.USD","LU1061106388.HKD","LU2087621335.USD","LU1066053197.SGD","LU0942090050.USD","SG9999014559.SGD","LU0234570918.USD","LU2468319806.SGD","SG9999015341.SGD","LU0106261372.USD","LU0203345920.USD","BK4516","BK4578","SG9999001440.SGD","IE00BFTCPJ56.SGD","LU2125909247.SGD","LU0203347892.USD","LU1585245621.USD","LU2125909593.SGD","LU1934455277.USD","MRK","LU1923622614.USD","BK4139","IE00BSNM7G36.USD","IE00BJT1NW94.SGD","LU2125154935.USD","LU2491050154.USD","IE00BZ1G4Q59.USD","LU0208291251.USD","IE00B7SZLL34.SGD","LU2112291526.USD","LU0320765646.SGD","LU1291159041.SGD","LU2125154778.USD","LU0114720955.EUR","LU2023250843.SGD","LU0006306889.USD","SG9999015952.SGD","LU1066051811.HKD","SGXZ57979304.SGD","LU1989771016.USD","SG9999014575.USD","LU0980610538.SGD","BK4566","LU1093756325.SGD","LU0965509283.SGD","LU0130102774.USD","LU0648001328.SGD","LU1201861249.SGD","LU2324357040.USD","SG9999013999.USD","LU0477156953.USD","LU1430594728.SGD","IE00BKVL7J92.USD","LU2089984988.USD","IE0009355771.USD","LU0265550359.USD","BK4588","LU0058720904.USD","LU0432979614.USD","BK4585","LU1934455863.HKD","BK4534","LU1093756168.USD","LU0965509010.AUD","BK4559","LU0238689110.USD","LU1162221912.USD","LU0122379950.USD","LU1674673428.USD","SG9999002232.USD","BK4532","LU1571399168.USD","LU2361044865.SGD","LU1983299246.USD","LU1037948897.HKD","IE00B19Z3B42.SGD","LU0130517989.USD","LU2491049909.HKD","LU0861579265.USD","IE00BJJMRZ35.SGD","LU1066051225.USD","LU0266013472.USD","LU1057294990.SGD","IE00BBT3K403.USD","IE00B2B36J28.USD","BK4533","LU1934455194.USD","LU1699723380.USD","LU0859254822.USD","IE00BLSP4452.SGD","LU1069347547.HKD","LU1917777945.USD","LU1778281490.HKD","LU2491050071.SGD","LU1929549753.HKD","LU1674673691.USD","LU1116320901.HKD","SG9999002224.SGD","LU1035773651.USD","LU2360032135.SGD","LU0234572021.USD","LU0211331839.USD","LU2433249047.HKD","SG9999015945.SGD","LU2361044949.HKD","LU1037948541.HKD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642432849","title":"Inovio Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2642432849","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642432849?lang=en_us&edition=fundamental","pubTime":"2026-06-09 05:25","pubTimestamp":1780953900,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Inovio Pharmaceuticals Inc.  advanced 1.87% to $1.09 Monday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index  rising 0.86% to 25,929.66 and the Dow Jones Industrial Average  falling 0.16% to 50,786.01.Inovio Pharmaceuticals Inc. closed 63.41% short of its 52-week high of $2.98, which the company reached on September 9th.The stock outperformed some of its competitors Monday, as Johnson & Johnson  fell 0.26% to $232.16, Statera Biopharma Inc.  remained unchanged, and Pfizer Inc.  fell 1.61% to $25.62.Trading volume  remained 1.7 million below its 50-day average volume of 3.2 M.Data source: Dow Jones Market Data, FactSet. Data compiled June 8, 2026.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4583","INO","BK4568","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642281434","title":"Quest Diagnostics Inc. Stock Underperforms Monday When Compared To Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2642281434","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642281434?lang=en_us&edition=fundamental","pubTime":"2026-06-09 05:05","pubTimestamp":1780952700,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Quest Diagnostics Inc.  slid 1.54% to $197.21 Monday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index  rising 0.30% to 7,405.73 and the Dow Jones Industrial Average  falling 0.16% to 50,786.01.The stock's fall snapped a four-day winning streak.Quest Diagnostics Inc. closed 7.63% short of its 52-week high of $213.50, which the company achieved on February 27th.The stock underperformed when compared to some of its competitors Monday, as UnitedHealth Group Inc.  rose 1.78% to $406.57, IQVIA Holdings Inc.  rose 0.13% to $183.69, and Centene Corp.  rose 4.33% to $65.03.Trading volume  remained 128,118 below its 50-day average volume of 900,546.Data source: Dow Jones Market Data, FactSet. Data compiled June 8, 2026.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently fro","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2506951958.HKD","LU1854103824.USD","LU2506951875.HKD","LU0950375773.USD","LU2506952097.USD","BK4567","LU0823417653.USD","BK4585","BK4583","BK4196","LU2506952170.USD","LU0823417737.USD","BK4588","DGX","LU1854104046.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642434685","title":"Merck, Gilead Discontinue Phase 3 Trial of Trodelvy, Keytruda to Treat Lung Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2642434685","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642434685?lang=en_us&edition=fundamental","pubTime":"2026-06-09 04:48","pubTimestamp":1780951721,"startTime":"0","endTime":"0","summary":"Merck  and Gilead Sciences  said Monday they are discontinuing a phase 3 trial assessing Gilead's Trodelvy combined with Merck's Keytruda compared to monotreatment with Keytruda in some people with non-small cell lung cancer, whose tumors expressed PD-L1.The decision was based on a recommendation from a Data Monitoring Committee after review of results from a final analysis of progression-free survival and an interim analysis of overall survival, the companies said.A numerical improvement in progression-free survival was seen, but it did not achieve statistical significance, the companies said, adding that the probability of reaching statistically significant overall survival is unlikely at a final analysis.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SG9999002232.USD","LU1066053197.SGD","MRK","SG9999015986.USD","LU2125909593.SGD","LU1934455863.HKD","LU1430594728.SGD","LU2112291526.USD","BK4566","LU2125154935.USD","LU0289739699.SGD","LU2087621335.USD","BK4588","LU1023059063.AUD","LU0965509101.SGD","LU0432979614.USD","SG9999015945.SGD","LU0106261372.USD","LU1069347547.HKD","LU1839511570.USD","LU2491049909.HKD","SG9999013999.USD","LU0211331839.USD","SG9999001176.USD","LU1116320737.USD","LU0320765992.SGD","LU0477156953.USD","IE00BSNM7G36.USD","LU2125154778.USD","LU0980610538.SGD","LU1093756325.SGD","BK4516","LU2361044865.SGD","LU2360032135.SGD","LU1778281490.HKD","BK4139","LU2106854487.HKD","LU1066051811.HKD","LU0130102774.USD","LU0823416689.USD","LU2491050154.USD","LU0965509283.SGD","LU0058720904.USD","LU1699723380.USD","LU1066051498.USD","LU1934455194.USD","LU0109394709.USD","SG9999014542.SGD","LU1674673691.USD","LU2023250504.SGD","SG9999015952.SGD","LU0006306889.USD","LU1035773651.USD","LU0122379950.USD","BK4534","SG9999014575.USD","IE0009355771.USD","IE00BLSP4239.USD","BK4533","LU0320765646.SGD","LU0859254822.USD","IE00B2B36J28.USD","SG9999014559.SGD","LU1983299246.USD","LU2324357040.USD","LU1941712348.USD","LU1093756168.USD","LU0868494708.USD","LU1929549753.HKD","IE00B7SZLL34.SGD","LU2433249047.HKD","LU2468319806.SGD","LU0203347892.USD","LU0265550946.USD","LU2361044949.HKD","LU1116320901.HKD","SGXZ57979304.SGD","LU1571399168.USD","LU1974910355.USD","IE00B19Z3581.USD","LU0234570918.USD","LU1162221912.USD","SG9999002224.SGD","IE00B4R5TH58.HKD","LU0203345920.USD","BK4578","IE0002270589.USD","BK4559","IE00BFTCPJ56.SGD","IE00B1BXHZ80.USD","LU1201861249.SGD","IE00BKVL7J92.USD","LU2491050071.SGD","LU2357627491.SGD","LU0868494617.USD","LU0648001328.SGD","LU1934455277.USD","LU1989772840.SGD","IE00BJJMRZ35.SGD","LU0114720955.EUR","LU1917777945.USD","LU1923622614.USD","LU1061106388.HKD","LU2125909247.SGD","BK4583","LU0965509010.AUD","SG9999001440.SGD","LU0208291251.USD","IE00BLSP4452.SGD","IE00BN8TJ469.HKD","LU0238689110.USD","LU0130517989.USD","LU1037948541.HKD","LU1066051225.USD","LU1941712264.USD","SG9999014567.USD","IE000M9KFDE8.USD","LU2023250843.SGD","LU0098860793.USD","LU0861579265.USD","LU1989772923.USD","LU2361045086.USD","LU1585245621.USD","SG9999015358.SGD","SG9999015978.USD","BK4532","BK4585","BK4007","LU0070302665.USD","LU0942090050.USD","LU1291159041.SGD","SG9999015341.SGD","GILD","LU1674673428.USD","IE0002141913.USD","LU2461242641.AUD","BK4568","LU0234572021.USD","LU0266013472.USD","LU0882574055.USD","IE00B19Z3B42.SGD","LU1037948897.HKD","BK4550","IE00BBT3K403.USD","LU1057294990.SGD","LU0265550359.USD","LU0320765489.SGD","LU0965508806.USD","SG9999001176.SGD","IE00B3T34201.USD","IE00BZ1G4Q59.USD","LU1989771016.USD","LU0985320562.USD","LU0889565916.HKD","LU2089984988.USD","IE00BJT1NW94.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642434540","title":"BRIEF-Merck And Gilead Provide Update On Phase 3 Keynote-D46/Evoke-03 Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2642434540","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642434540?lang=en_us&edition=fundamental","pubTime":"2026-06-09 04:47","pubTimestamp":1780951657,"startTime":"0","endTime":"0","summary":"BRIEF-Merck And Gilead Provide Update On Phase 3 Keynote-D46/Evoke-03 StudyJune 8 (Reuters) - Gilead Sciences, Inc GILD.O:MERCK AND GILEAD PROVIDE UPDATE ON PHASE 3 KEYNOTE-D46/EVOKE-03 STUDYGILEAD: S","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260608:nTUA94BJ0F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1430594728.SGD","LU1917777945.USD","IE0002270589.USD","MRK","BK4516","BK4007","LU0265550946.USD","LU1035773651.USD","LU1923622614.USD","LU2361044865.SGD","SG9999015952.SGD","LU1839511570.USD","LU0942090050.USD","LU0098860793.USD","LU2106854487.HKD","BK4583","LU2112291526.USD","LU1066051811.HKD","LU1699723380.USD","IE00BZ1G4Q59.USD","LU2089984988.USD","LU2125909247.SGD","LU1674673428.USD","LU0985320562.USD","SG9999013999.USD","LU1093756168.USD","LU1066051225.USD","LU0070302665.USD","LU0208291251.USD","IE00B2B36J28.USD","LU2023250504.SGD","LU1778281490.HKD","LU1116320901.HKD","SG9999014575.USD","LU0882574055.USD","LU0432979614.USD","LU1983299246.USD","LU1974910355.USD","LU0203345920.USD","LU0106261372.USD","LU0109394709.USD","LU0965509101.SGD","GILD","LU1069347547.HKD","IE00BJT1NW94.SGD","LU1585245621.USD","LU2461242641.AUD","LU2433249047.HKD","LU1061106388.HKD","LU0266013472.USD","LU2491050154.USD","LU1934455277.USD","LU1291159041.SGD","IE00B3T34201.USD","LU1066053197.SGD","LU2087621335.USD","SGXZ57979304.SGD","IE00BKVL7J92.USD","LU0861579265.USD","LU1941712348.USD","LU0006306889.USD","LU2125909593.SGD","LU0859254822.USD","IE00B4R5TH58.HKD","LU1066051498.USD","IE00BN8TJ469.HKD","LU0265550359.USD","LU0234572021.USD","LU0965509010.AUD","LU0130102774.USD","LU0320765646.SGD","SG9999015978.USD","LU1989771016.USD","LU0889565916.HKD","LU0203347892.USD","IE00BJJMRZ35.SGD","LU1674673691.USD","LU2491049909.HKD","IE00B7SZLL34.SGD","LU1037948897.HKD","IE00BBT3K403.USD","LU1093756325.SGD","LU2360032135.SGD","LU1934455863.HKD","LU1057294990.SGD","LU1201861249.SGD","LU0648001328.SGD","SG9999014542.SGD","IE0009355771.USD","LU0980610538.SGD","SG9999015341.SGD","SG9999001176.USD","LU0320765489.SGD","LU1037948541.HKD","BK4588","BK4566","BK4585","LU2491050071.SGD","IE00BLSP4452.SGD","LU1941712264.USD","LU2361045086.USD","LU2125154935.USD","BK4550","LU0289739699.SGD","BK4578","IE00BSNM7G36.USD","SG9999015358.SGD","IE0002141913.USD","LU0114720955.EUR","LU0965509283.SGD","LU0868494617.USD","LU0058720904.USD","LU2023250843.SGD","LU0234570918.USD","LU1934455194.USD","LU0477156953.USD","LU1989772840.SGD","LU1929549753.HKD","LU2361044949.HKD","LU1023059063.AUD","BK4534","LU1116320737.USD","LU2125154778.USD","SG9999001440.SGD","BK4532","LU2357627491.SGD","LU0823416689.USD","LU0868494708.USD","SG9999015945.SGD","SG9999014567.USD","SG9999014559.SGD","LU0130517989.USD","BK4559","LU1989772923.USD","LU2468319806.SGD","IE00BLSP4239.USD","LU1571399168.USD","IE000M9KFDE8.USD","BK4533","IE00B19Z3581.USD","LU0122379950.USD","SG9999015986.USD","IE00B19Z3B42.SGD","SG9999002224.SGD","BK4139","LU1162221912.USD","IE00BFTCPJ56.SGD","LU0320765992.SGD","SG9999002232.USD","LU0965508806.USD","SG9999001176.SGD","LU0211331839.USD","BK4568","IE00B1BXHZ80.USD","LU0238689110.USD","LU2324357040.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642434394","title":"Merck, Gilead announce discontinuation of Phase 3 KEYNOTE-D46/EVOKE-03 study","url":"https://stock-news.laohu8.com/highlight/detail?id=2642434394","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642434394?lang=en_us&edition=fundamental","pubTime":"2026-06-09 04:35","pubTimestamp":1780950936,"startTime":"0","endTime":"0","summary":"Merck (MRK) and Gilead Sciences (GILD) announced the discontinuation of the Phase 3 KEYNOTE-D46/EVOKE-03 study investigating Gilead’s Trodelvy in c...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/merck-gilead-announce-discontinuation-of-phase-3-keynote-d46-evoke-03-study-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/merck-gilead-announce-discontinuation-of-phase-3-keynote-d46-evoke-03-study-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0648001328.SGD","BK4534","LU1037948541.HKD","LU1917777945.USD","SG9999014567.USD","LU0980610538.SGD","IE0002270589.USD","IE00BJJMRZ35.SGD","BK4139","SG9999001176.SGD","LU0289739699.SGD","LU0265550359.USD","LU1066051811.HKD","LU1061106388.HKD","LU0114720955.EUR","LU1934455863.HKD","SG9999015986.USD","LU2491049909.HKD","LU2461242641.AUD","LU0823416689.USD","LU1201861249.SGD","LU1057294990.SGD","BK4532","LU1674673428.USD","LU0266013472.USD","SGXZ57979304.SGD","LU0106261372.USD","LU0965509283.SGD","BK4585","LU1974910355.USD","IE00B7SZLL34.SGD","LU1571399168.USD","LU0208291251.USD","LU2433249047.HKD","LU1674673691.USD","BK4533","IE00B3T34201.USD","IE00BLSP4239.USD","LU1162221912.USD","MRK","SG9999002232.USD","LU1116320901.HKD","LU2089984988.USD","LU0058720904.USD","LU2087621335.USD","LU1069347547.HKD","IE00B2B36J28.USD","IE00BZ1G4Q59.USD","IE00B19Z3581.USD","LU1934455277.USD","LU0965509101.SGD","LU0098860793.USD","LU2361045086.USD","LU0477156953.USD","LU1585245621.USD","LU1989772923.USD","LU0203347892.USD","LU1929549753.HKD","SG9999014542.SGD","BK4578","LU0211331839.USD","LU1430594728.SGD","IE000M9KFDE8.USD","LU2125909593.SGD","LU0942090050.USD","LU2125154778.USD","LU1093756325.SGD","LU1066051498.USD","LU0130102774.USD","LU1934455194.USD","LU1023059063.AUD","IE00BJT1NW94.SGD","LU0859254822.USD","LU0965508806.USD","LU2468319806.SGD","SG9999015978.USD","LU2361044949.HKD","LU2106854487.HKD","IE0002141913.USD","LU2125154935.USD","IE00B4R5TH58.HKD","BK4007","IE00B1BXHZ80.USD","LU1989772840.SGD","BK4568","BK4559","LU0109394709.USD","SG9999015358.SGD","LU0130517989.USD","SG9999015341.SGD","LU0006306889.USD","LU1941712348.USD","LU0320765992.SGD","LU1941712264.USD","LU1839511570.USD","LU2491050154.USD","LU1066053197.SGD","LU0868494708.USD","LU0861579265.USD","IE00BBT3K403.USD","LU2125909247.SGD","LU0203345920.USD","SG9999015945.SGD","LU1116320737.USD","LU2023250504.SGD","SG9999014575.USD","IE00B19Z3B42.SGD","BK4550","SG9999014559.SGD","LU1983299246.USD","LU1037948897.HKD","LU1699723380.USD","SG9999001440.SGD","SG9999002224.SGD","IE00BLSP4452.SGD","LU0265550946.USD","LU0882574055.USD","BK4516","LU1923622614.USD","LU1066051225.USD","LU0889565916.HKD","LU2491050071.SGD","SG9999001176.USD","BK4588","LU0234572021.USD","BK4583","IE00BSNM7G36.USD","LU0122379950.USD","SG9999015952.SGD","LU2023250843.SGD","LU1291159041.SGD","LU0234570918.USD","LU1035773651.USD","IE0009355771.USD","LU0868494617.USD","LU0238689110.USD","IE00BKVL7J92.USD","IE00BN8TJ469.HKD","LU1093756168.USD","LU0965509010.AUD","LU2361044865.SGD","GILD","LU2324357040.USD","LU2357627491.SGD","LU0985320562.USD","LU1989771016.USD","BK4566","LU0432979614.USD","LU0320765489.SGD","LU2112291526.USD","IE00BFTCPJ56.SGD","LU0320765646.SGD","LU1778281490.HKD","SG9999013999.USD","LU0070302665.USD","LU2360032135.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642431046","title":"Gilead, Merck say once-weekly HIV pill meets Phase 3 endpoint in ISLEND trials","url":"https://stock-news.laohu8.com/highlight/detail?id=2642431046","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642431046?lang=en_us&edition=fundamental","pubTime":"2026-06-09 04:35","pubTimestamp":1780950928,"startTime":"0","endTime":"0","summary":"Gilead disclosed positive topline Phase 3 results for an investigational once-weekly oral HIV tablet combining islatravir with lenacapavir.ISLEND-1, a blinded switch study, met its main goal, supporting comparable viral control versus Biktarvy.ISLEND-2, an open-label switch study, also met its main goal, showing comparable performance versus standard daily regimens.Safety was broadly in line with comparators, with no new concerns flagged.Detailed findings will be submitted for presentation at a future scientific congress, ahead of planned global regulatory filings.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Gilead Sciences Inc. published the original content used to generate this news brief via Business Wire  on June 08, 2026, and ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260608:nNDL1B4gZb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LU0266013472.USD","LU0265550946.USD","LU0234570918.USD","LU1934455863.HKD","IE00BKVL7J92.USD","LU0289739699.SGD","SG9999014567.USD","IE00B7SZLL34.SGD","LU1430594728.SGD","LU1934455277.USD","LU0859254822.USD","LU2106854487.HKD","LU0980610538.SGD","LU0477156953.USD","LU0868494617.USD","LU1571399168.USD","IE00BLSP4239.USD","LU0234572021.USD","LU0889565916.HKD","LU1941712348.USD","IE00BN8TJ469.HKD","LU0823416689.USD","LU0265550359.USD","LU1989771016.USD","LU0432979614.USD","LU1037948541.HKD","LU1066051811.HKD","IE000M9KFDE8.USD","LU1035773651.USD","LU1037948897.HKD","LU1057294990.SGD","LU1989772923.USD","LU0320765489.SGD","LU2361044865.SGD","SG9999001440.SGD","IE00BJT1NW94.SGD","LU1066051498.USD","IE00B19Z3B42.SGD","GILD","LU1674673691.USD","IE00BJJMRZ35.SGD","LU1093756325.SGD","LU1934455194.USD","LU2361044949.HKD","LU2125909247.SGD","LU2360032135.SGD","LU1839511570.USD","SG9999002232.USD","BK4139","LU1989772840.SGD","BK4532","IE00BZ1G4Q59.USD","LU1061106388.HKD","LU0006306889.USD","IE00BSNM7G36.USD","LU2491049909.HKD","LU2023250843.SGD","LU1066053197.SGD","LU0965509010.AUD","LU1201861249.SGD","LU0320765646.SGD","LU0211331839.USD","LU0114720955.EUR","BK4534","BK4516","LU1023059063.AUD","LU2089984988.USD","LU0965508806.USD","LU1929549753.HKD","BK4559","BK4550","LU0106261372.USD","SG9999015978.USD","SG9999014542.SGD","LU1162221912.USD","IE0009355771.USD","LU0942090050.USD","SG9999001176.USD","SG9999015952.SGD","SGXZ57979304.SGD","BK4568","BK4588","LU0320765992.SGD","SG9999014559.SGD","IE0002141913.USD","SG9999014575.USD","MRK","LU2491050154.USD","LU0130102774.USD","SG9999001176.SGD","LU1066051225.USD","LU0861579265.USD","LU1674673428.USD","LU0965509283.SGD","BK4566","LU1291159041.SGD","LU2324357040.USD","LU0238689110.USD","LU1069347547.HKD","BK4007","LU1778281490.HKD","LU1585245621.USD","LU1917777945.USD","LU0203347892.USD","LU2125154935.USD","IE00B3T34201.USD","IE00B4R5TH58.HKD","LU0868494708.USD","SG9999015341.SGD","LU0130517989.USD","LU2461242641.AUD","LU1116320737.USD","LU2125154778.USD","LU1941712264.USD","BK4578","IE00B1BXHZ80.USD","LU0648001328.SGD","SG9999015358.SGD","LU2023250504.SGD","LU0203345920.USD","LU2125909593.SGD","IE00BBT3K403.USD","LU0058720904.USD","SG9999002224.SGD","LU0122379950.USD","LU2112291526.USD","IE00B2B36J28.USD","IE00B19Z3581.USD","BK4583","LU0208291251.USD","LU1923622614.USD","LU2491050071.SGD","LU2357627491.SGD","IE0002270589.USD","LU0098860793.USD","SG9999013999.USD","LU0109394709.USD","LU1699723380.USD","IE00BFTCPJ56.SGD","IE00BLSP4452.SGD","LU2433249047.HKD","LU1983299246.USD","LU1093756168.USD","SG9999015986.USD","LU2468319806.SGD","LU0070302665.USD","LU2087621335.USD","LU0985320562.USD","LU2361045086.USD","LU0882574055.USD","LU1116320901.HKD","LU0965509101.SGD","SG9999015945.SGD","BK4533","LU1974910355.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642743106","title":"Gilead: Co, Merck Plan to File Phase 3 Data From Islend Trials of Islatravir/Lenacapavir With Regulatory Authorities Globally","url":"https://stock-news.laohu8.com/highlight/detail?id=2642743106","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642743106?lang=en_us&edition=fundamental","pubTime":"2026-06-09 04:35","pubTimestamp":1780950908,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260608:nP8N3WG06T:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1934455863.HKD","IE00B19Z3B42.SGD","BK4007","BK4532","BK4566","LU0109394709.USD","BK4139","IE00B3T34201.USD","MKGAF","SG9999015986.USD","LU0122379950.USD","BK4588","LU1674673428.USD","SG9999015978.USD","LU0234570918.USD","LU2087621335.USD","LU0823416689.USD","LU0965509101.SGD","LU1057294990.SGD","LU1571399168.USD","LU0889565916.HKD","BK4583","LU0114720955.EUR","LU0965509010.AUD","LU1037948541.HKD","BK4568","LU2468319806.SGD","IE00B7SZLL34.SGD","LU1934455194.USD","SG9999015952.SGD","LU0861579265.USD","LU1066053197.SGD","IE00BZ1G4Q59.USD","LU1585245621.USD","LU2089984988.USD","LU2112291526.USD","SG9999015945.SGD","LU1066051498.USD","BK4585","GILD","IE0002270589.USD","LU1061106388.HKD","LU0320765992.SGD","LU0965508806.USD","BK4578","IE00BKVL7J92.USD","IE00B19Z3581.USD","LU0058720904.USD","LU1674673691.USD","LU1934455277.USD","LU1778281490.HKD","LU1023059063.AUD","BK4550","IE00BSNM7G36.USD","LU0289739699.SGD","LU0882574055.USD","LU1037948897.HKD","LU1430594728.SGD","LU1839511570.USD","LU0965509283.SGD","LU2324357040.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642431095","title":"Gilead: Announces Positive Topline Results From Two Phase 3 Studies Evaluating Oral Once-Weekly Hiv Treatment Islatravir and Lenacapavir","url":"https://stock-news.laohu8.com/highlight/detail?id=2642431095","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642431095?lang=en_us&edition=fundamental","pubTime":"2026-06-09 04:35","pubTimestamp":1780950908,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260608:nP8N3WG06T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0823416689.USD","LU0889565916.HKD","LU1023059063.AUD","LU2089984988.USD","BK4578","LU1061106388.HKD","LU1571399168.USD","LU1839511570.USD","GILD","LU0058720904.USD","LU2468319806.SGD","SG9999015978.USD","LU0965509010.AUD","LU1585245621.USD","LU2087621335.USD","BK4532","LU1430594728.SGD","IE00B7SZLL34.SGD","LU1066053197.SGD","LU0882574055.USD","LU0965509101.SGD","LU1674673428.USD","SG9999015945.SGD","LU0965508806.USD","LU1057294990.SGD","LU2112291526.USD","SG9999015986.USD","LU1037948897.HKD","LU2324357040.USD","IE00B19Z3B42.SGD","LU0114720955.EUR","LU0861579265.USD","IE0002270589.USD","LU1778281490.HKD","LU0234570918.USD","BK4588","IE00BKVL7J92.USD","BK4568","LU1674673691.USD","IE00B3T34201.USD","LU0122379950.USD","LU1037948541.HKD","IE00BZ1G4Q59.USD","LU1934455194.USD","SG9999015952.SGD","BK4139","LU1934455863.HKD","LU0109394709.USD","BK4550","LU1066051498.USD","LU1934455277.USD","BK4583","LU0289739699.SGD","LU0320765992.SGD","BK4566","IE00B19Z3581.USD","LU0965509283.SGD","IE00BSNM7G36.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642011431","title":"Gilead: No New Safety Concerns Were Identified in Both Trials With Islatravir/Lenacapavir","url":"https://stock-news.laohu8.com/highlight/detail?id=2642011431","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642011431?lang=en_us&edition=fundamental","pubTime":"2026-06-09 04:35","pubTimestamp":1780950908,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260608:nP8N3WG06T:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1674673691.USD","LU1839511570.USD","SG9999015978.USD","LU0109394709.USD","LU0861579265.USD","LU1934455194.USD","LU1674673428.USD","LU1778281490.HKD","IE00B3T34201.USD","LU0965509101.SGD","LU0889565916.HKD","SG9999015952.SGD","IE0002270589.USD","IE00B7SZLL34.SGD","LU1571399168.USD","LU0882574055.USD","BK4588","IE00BKVL7J92.USD","LU0965509010.AUD","BK4532","BK4583","BK4568","LU0965509283.SGD","LU0122379950.USD","LU1037948541.HKD","LU0823416689.USD","LU2089984988.USD","LU0320765992.SGD","LU1430594728.SGD","LU0234570918.USD","IE00BSNM7G36.USD","LU0114720955.EUR","LU0965508806.USD","LU2112291526.USD","SG9999015945.SGD","BK4550","SG9999015986.USD","BK4139","GILD","LU1037948897.HKD","LU1934455277.USD","LU2324357040.USD","LU2087621335.USD","LU2468319806.SGD","BK4578","LU1585245621.USD","LU1061106388.HKD","BK4566","LU1066051498.USD","LU1066053197.SGD","IE00B19Z3581.USD","IE00B19Z3B42.SGD","LU1023059063.AUD","LU0289739699.SGD","BK4585","LU1057294990.SGD","LU0058720904.USD","IE00BZ1G4Q59.USD","LU1934455863.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642431034","title":"Quest Diagnostics SVP Clinical Solutions Karthik Kuppusamy disposes of shares worth $1,629,400","url":"https://stock-news.laohu8.com/highlight/detail?id=2642431034","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642431034?lang=en_us&edition=fundamental","pubTime":"2026-06-09 04:33","pubTimestamp":1780950789,"startTime":"0","endTime":"0","summary":"Quest Diagnostics SVP, Clinical Solutions Karthik Kuppusamy reported option exercises on June 4, 2026, acquiring 8,147 common shares.He sold 8,147 shares at USD 200, leaving 13,510 shares owned directly.He also reported 1,721 shares held in a 401 plan, plus 358 shares held by a trust.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Quest Diagnostics Incorporated published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 08, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260608:nNDL73x8zR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Quest Diagnostics SVP Clinical Solutions Karthik Kuppusamy disposes of shares worth $1,629,400","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1854103824.USD","DGX","LU1854104046.USD","BK4588","LU0823417737.USD","BK4583","BK4585","BK4196","LU0823417653.USD","LU2506952170.USD","LU2506951875.HKD","BK4567","LU0950375773.USD","LU2506952097.USD","LU2506951958.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642431204","title":"Merck, Gilead halt Phase 3 KEYNOTE-D46/EVOKE-03 lung cancer trial after PFS misses significance","url":"https://stock-news.laohu8.com/highlight/detail?id=2642431204","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642431204?lang=en_us&edition=fundamental","pubTime":"2026-06-09 04:30","pubTimestamp":1780950633,"startTime":"0","endTime":"0","summary":"Merck and Gilead discontinued the Phase 3 KEYNOTE-D46/EVOKE-03 trial in first-line metastatic non-small cell lung cancer.The Trodelvy-Keytruda combination showed a directional improvement in delaying disease worsening, but missed the study’s primary efficacy bar.An independent monitoring committee judged a meaningful survival benefit was unlikely, driving the decision to stop the study.Safety matched the known profiles of both drugs, with no new signals flagged.Results have not been presented yet; the companies plan to present the data at a future medical meeting.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Merck & Co. Inc. published the original content used to generate this news brief via Business Wire  on June 08, 2026, and is so","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260608:nNDL4gr1kb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2361045086.USD","BK4533","LU0208291251.USD","LU1037948897.HKD","SG9999013999.USD","IE00BN8TJ469.HKD","BK4534","LU1035773651.USD","SG9999015986.USD","LU1923622614.USD","LU2491049909.HKD","IE0002270589.USD","LU1934455863.HKD","LU2125909247.SGD","LU2087621335.USD","LU1066051811.HKD","BK4516","BK4588","LU1839511570.USD","LU2361044949.HKD","IE00B1BXHZ80.USD","IE00BJJMRZ35.SGD","LU2357627491.SGD","IE00B2B36J28.USD","LU0965509010.AUD","SG9999015358.SGD","LU0965509101.SGD","LU0114720955.EUR","LU2125154935.USD","LU0477156953.USD","LU1778281490.HKD","LU0868494617.USD","LU0234572021.USD","LU0203345920.USD","LU1674673428.USD","LU2112291526.USD","LU1989771016.USD","LU0320765489.SGD","SG9999014567.USD","BK4578","LU1989772923.USD","SG9999015341.SGD","BK4532","LU1983299246.USD","LU2125909593.SGD","MRK","LU2433249047.HKD","LU0320765646.SGD","BK4559","LU1066053197.SGD","LU1037948541.HKD","LU0648001328.SGD","LU0289739699.SGD","LU1201861249.SGD","IE000M9KFDE8.USD","LU2361044865.SGD","LU0965509283.SGD","IE00B3T34201.USD","LU1093756325.SGD","IE00BSNM7G36.USD","LU0130102774.USD","LU0266013472.USD","LU1699723380.USD","LU1934455194.USD","LU0320765992.SGD","LU0965508806.USD","LU2125154778.USD","LU2089984988.USD","BK4139","SG9999014559.SGD","LU1585245621.USD","LU1941712348.USD","LU0070302665.USD","LU0006306889.USD","BK4583","LU1023059063.AUD","LU1989772840.SGD","LU0122379950.USD","IE00BKVL7J92.USD","LU0211331839.USD","LU2106854487.HKD","SG9999001176.USD","LU2324357040.USD","LU2360032135.SGD","SG9999015978.USD","BK4550","LU2491050071.SGD","SG9999001440.SGD","IE00BLSP4239.USD","SGXZ57979304.SGD","LU2491050154.USD","LU0238689110.USD","IE00BBT3K403.USD","LU0859254822.USD","LU1116320901.HKD","IE0002141913.USD","LU0265550359.USD","IE00BLSP4452.SGD","LU0130517989.USD","LU0861579265.USD","LU0098860793.USD","LU0823416689.USD","IE00B19Z3B42.SGD","IE00BJT1NW94.SGD","SG9999001176.SGD","IE00BFTCPJ56.SGD","LU0109394709.USD","LU1116320737.USD","IE00B4R5TH58.HKD","IE00BZ1G4Q59.USD","BK4566","BK4007","SG9999002224.SGD","LU1674673691.USD","LU1974910355.USD","GILD","SG9999002232.USD","LU1941712264.USD","IE00B7SZLL34.SGD","LU0234570918.USD","LU0265550946.USD","BK4568","LU0889565916.HKD","LU1057294990.SGD","LU0106261372.USD","IE00B19Z3581.USD","LU0432979614.USD","LU0882574055.USD","LU1069347547.HKD","LU0985320562.USD","LU1066051498.USD","IE0009355771.USD","LU2461242641.AUD","LU1061106388.HKD","LU0980610538.SGD","SG9999014542.SGD","LU2023250504.SGD","LU1430594728.SGD","LU1093756168.USD","LU0942090050.USD","LU1934455277.USD","LU0203347892.USD","BK4585","LU0058720904.USD","LU2468319806.SGD","LU1162221912.USD","LU1066051225.USD","SG9999014575.USD","SG9999015945.SGD","SG9999015952.SGD","LU1291159041.SGD","LU1571399168.USD","LU1929549753.HKD","LU1917777945.USD","LU0868494708.USD","LU2023250843.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642431222","title":"Gilead:  Discontinuation of Phase 3 Keynote-D46/Evoke-03 Study Investigating Gilead's Trodelvy in Combination With Keytruda","url":"https://stock-news.laohu8.com/highlight/detail?id=2642431222","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642431222?lang=en_us&edition=fundamental","pubTime":"2026-06-09 04:30","pubTimestamp":1780950600,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260608:nTUA94BJ0F:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2112291526.USD","IE00B19Z3B42.SGD","LU2106854487.HKD","LU1430594728.SGD","LU2023250843.SGD","LU0985320562.USD","LU0882574055.USD","IE00BJJMRZ35.SGD","LU1989772840.SGD","IE0002141913.USD","LU0320765646.SGD","SG9999001440.SGD","SG9999015978.USD","BK4588","LU0889565916.HKD","LU0432979614.USD","LU2089984988.USD","LU1923622614.USD","LU1917777945.USD","LU1674673428.USD","LU0109394709.USD","LU0965508806.USD","IE00BZ1G4Q59.USD","LU1934455863.HKD","LU0859254822.USD","LU0122379950.USD","BK4007","LU0234572021.USD","LU0868494708.USD","LU0058720904.USD","LU1989771016.USD","LU2361044865.SGD","LU0130102774.USD","SG9999014575.USD","IE00BLSP4452.SGD","LU1974910355.USD","LU2125909593.SGD","LU1778281490.HKD","LU0965509283.SGD","LU1839511570.USD","LU1929549753.HKD","LU1989772923.USD","SG9999002224.SGD","IE00BSNM7G36.USD","IE00BFTCPJ56.SGD","LU0265550359.USD","LU0266013472.USD","LU2491050071.SGD","IE00BN8TJ469.HKD","BK4532","SG9999014542.SGD","GILD","LU1066051225.USD","SGXZ57979304.SGD","BK4568","IE00BJT1NW94.SGD","LU2361045086.USD","LU1699723380.USD","LU1674673691.USD","LU1934455277.USD","LU2324357040.USD","SG9999014567.USD","LU0942090050.USD","LU0106261372.USD","SG9999001176.USD","LU2125909247.SGD","LU1066053197.SGD","LU2023250504.SGD","BK4559","LU0477156953.USD","LU2125154778.USD","LU1037948541.HKD","LU0648001328.SGD","LU2361044949.HKD","IE0009355771.USD","LU0234570918.USD","SG9999015952.SGD","IE00B7SZLL34.SGD","SG9999015358.SGD","IE00B4R5TH58.HKD","LU0861579265.USD","SG9999015986.USD","MRK","SG9999014559.SGD","BK4566","BK4550","LU1291159041.SGD","LU0130517989.USD","LU2491049909.HKD","IE00B19Z3581.USD","LU2357627491.SGD","IE00B3T34201.USD","SG9999002232.USD","LU1983299246.USD","SG9999013999.USD","LU1035773651.USD","LU1116320901.HKD","LU2491050154.USD","LU0980610538.SGD","LU0203347892.USD","BK4534","BK4533","LU0006306889.USD","LU0211331839.USD","BK4583","LU1093756325.SGD","LU1057294990.SGD","LU1934455194.USD","LU0823416689.USD","LU1066051811.HKD","LU0070302665.USD","LU2433249047.HKD","LU1023059063.AUD","LU2468319806.SGD","LU1093756168.USD","LU0098860793.USD","LU1571399168.USD","IE00BLSP4239.USD","LU1201861249.SGD","IE00BBT3K403.USD","LU1037948897.HKD","IE00B1BXHZ80.USD","LU1941712264.USD","IE000M9KFDE8.USD","LU0265550946.USD","LU1116320737.USD","LU2461242641.AUD","LU2087621335.USD","LU0203345920.USD","LU0238689110.USD","BK4516","LU1069347547.HKD","LU1162221912.USD","LU0289739699.SGD","LU0868494617.USD","LU0320765489.SGD","SG9999015945.SGD","IE00B2B36J28.USD","LU0965509101.SGD","BK4139","LU1941712348.USD","IE00BKVL7J92.USD","LU0114720955.EUR","LU1061106388.HKD","LU0320765992.SGD","LU1585245621.USD","SG9999001176.SGD","LU0965509010.AUD","IE0002270589.USD","LU2125154935.USD","SG9999015341.SGD","LU1066051498.USD","BK4585","LU2360032135.SGD","LU0208291251.USD","BK4578"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642279431","title":"Gilead: Safety Profile of Trodelvy in Combination With Keytruda Consistent With Known Safety of Each Agent","url":"https://stock-news.laohu8.com/highlight/detail?id=2642279431","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642279431?lang=en_us&edition=fundamental","pubTime":"2026-06-09 04:30","pubTimestamp":1780950600,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260608:nTUA94BJ0F:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4566","LU1983299246.USD","LU0289739699.SGD","LU1162221912.USD","LU0965509283.SGD","LU2125909247.SGD","LU0238689110.USD","LU1989772923.USD","SG9999014559.SGD","MRK","IE0002141913.USD","LU1037948897.HKD","LU2491050071.SGD","LU0823416689.USD","LU1116320737.USD","LU0114720955.EUR","IE00BJT1NW94.SGD","LU0106261372.USD","LU1037948541.HKD","SG9999015986.USD","LU2324357040.USD","LU0006306889.USD","LU0122379950.USD","LU0211331839.USD","LU0942090050.USD","SG9999013999.USD","LU0130517989.USD","SG9999015341.SGD","BK4583","SG9999015945.SGD","LU0965509101.SGD","SG9999002232.USD","LU0109394709.USD","LU1571399168.USD","LU0058720904.USD","IE00BFTCPJ56.SGD","LU1066053197.SGD","IE00BJJMRZ35.SGD","LU2089984988.USD","LU2361045086.USD","LU1934455863.HKD","LU2357627491.SGD","GILD","LU1116320901.HKD","LU0208291251.USD","LU0868494708.USD","LU1699723380.USD","SG9999001176.SGD","LU0234570918.USD","LU1778281490.HKD","SG9999002224.SGD","LU0859254822.USD","LU1923622614.USD","SG9999001176.USD","SG9999015358.SGD","LU1989772840.SGD","IE000M9KFDE8.USD","LU1069347547.HKD","LU0320765992.SGD","LU1023059063.AUD","LU2361044865.SGD","LU2125909593.SGD","LU1585245621.USD","BK4007","BK4534","LU0965509010.AUD","IE00B7SZLL34.SGD","LU0266013472.USD","LU2433249047.HKD","BK4550","LU1061106388.HKD","BK4533","LU0648001328.SGD","LU1917777945.USD","LU0234572021.USD","LU1989771016.USD","LU2461242641.AUD","LU2468319806.SGD","LU2491049909.HKD","LU0320765489.SGD","LU1941712264.USD","LU1941712348.USD","SG9999015978.USD","LU2361044949.HKD","SG9999014567.USD","IE00BBT3K403.USD","IE00B19Z3581.USD","SG9999014542.SGD","LU0965508806.USD","LU1066051225.USD","LU2360032135.SGD","IE00BLSP4452.SGD","LU1066051811.HKD","IE00BLSP4239.USD","LU2023250504.SGD","LU0203347892.USD","IE00B1BXHZ80.USD","IE0009355771.USD","IE00B3T34201.USD","IE00BN8TJ469.HKD","LU1093756168.USD","LU0130102774.USD","LU1674673691.USD","IE00B2B36J28.USD","IE00BZ1G4Q59.USD","LU0861579265.USD","LU0203345920.USD","SG9999014575.USD","LU1057294990.SGD","IE00B4R5TH58.HKD","LU0980610538.SGD","IE00BKVL7J92.USD","BK4578","LU0265550359.USD","LU1839511570.USD","LU0477156953.USD","LU1430594728.SGD","BK4585","BK4568","LU2087621335.USD","LU0985320562.USD","IE00BSNM7G36.USD","LU1674673428.USD","BK4559","LU1934455194.USD","LU1934455277.USD","LU0882574055.USD","SG9999015952.SGD","LU1974910355.USD","LU0098860793.USD","LU2023250843.SGD","BK4139","LU1929549753.HKD","BK4532","LU0889565916.HKD","LU2112291526.USD","LU2125154935.USD","LU0265550946.USD","LU2491050154.USD","LU1291159041.SGD","LU0868494617.USD","LU1201861249.SGD","LU0070302665.USD","LU2106854487.HKD","BK4588","LU1093756325.SGD","LU2125154778.USD","IE0002270589.USD","LU1066051498.USD","LU0432979614.USD","BK4516","LU1035773651.USD","SG9999001440.SGD","IE00B19Z3B42.SGD","LU0320765646.SGD","SGXZ57979304.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642221431","title":"Gilead: Study Did Not Achieve Statistical Significance for Progression-Free or Overall Survival","url":"https://stock-news.laohu8.com/highlight/detail?id=2642221431","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642221431?lang=en_us&edition=fundamental","pubTime":"2026-06-09 04:30","pubTimestamp":1780950600,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260608:nTUA94BJ0F:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1571399168.USD","LU2324357040.USD","BK4139","LU1037948897.HKD","LU1674673428.USD","LU0058720904.USD","LU1066053197.SGD","BK4588","SG9999015945.SGD","LU1778281490.HKD","LU1839511570.USD","LU0861579265.USD","LU2112291526.USD","IE00B19Z3B42.SGD","BK4583","LU0965509010.AUD","LU1934455194.USD","BK4568","IE00BSNM7G36.USD","LU1057294990.SGD","LU2468319806.SGD","SG9999015952.SGD","LU2087621335.USD","LU0320765992.SGD","LU1066051498.USD","BK4578","BK4550","SG9999015986.USD","GILD","LU0234570918.USD","LU0823416689.USD","LU1585245621.USD","BK4566","IE00BKVL7J92.USD","IE00B7SZLL34.SGD","IE00B3T34201.USD","LU1023059063.AUD","LU0882574055.USD","LU0109394709.USD","IE0002270589.USD","LU1037948541.HKD","IE00B19Z3581.USD","BK4532","LU0289739699.SGD","LU0965508806.USD","LU0965509283.SGD","LU1674673691.USD","LU1934455863.HKD","BK4585","LU2089984988.USD","LU0889565916.HKD","LU1430594728.SGD","SG9999015978.USD","LU0965509101.SGD","IE00BZ1G4Q59.USD","LU0122379950.USD","LU1934455277.USD","LU1061106388.HKD","LU0114720955.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642143127","title":"Gilead: No Changes to Ongoing Trodelvy or Merck Studies","url":"https://stock-news.laohu8.com/highlight/detail?id=2642143127","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642143127?lang=en_us&edition=fundamental","pubTime":"2026-06-09 04:30","pubTimestamp":1780950600,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260608:nTUA94BJ0F:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4583","SG9999015952.SGD","LU1061106388.HKD","LU1934455277.USD","LU2357627491.SGD","LU0980610538.SGD","IE00B2B36J28.USD","SG9999015986.USD","SG9999001176.USD","LU2491050154.USD","LU1162221912.USD","LU2125909247.SGD","LU2023250504.SGD","SG9999014542.SGD","LU0320765646.SGD","LU0882574055.USD","LU1674673428.USD","LU0965508806.USD","LU2125909593.SGD","GILD","LU0648001328.SGD","BK4550","BK4588","SG9999015978.USD","BK4007","LU1037948897.HKD","LU2112291526.USD","IE00BKVL7J92.USD","LU0265550946.USD","IE00B3T34201.USD","LU1989772840.SGD","SG9999015358.SGD","LU0868494617.USD","LU1035773651.USD","SG9999002224.SGD","LU2106854487.HKD","BK4139","LU0070302665.USD","LU0477156953.USD","LU0320765489.SGD","IE00BZ1G4Q59.USD","LU2361044949.HKD","SG9999013999.USD","LU0265550359.USD","LU2433249047.HKD","LU1585245621.USD","LU0432979614.USD","LU1116320737.USD","LU1989772923.USD","LU0823416689.USD","SGXZ57979304.SGD","LU2491049909.HKD","LU0985320562.USD","LU1201861249.SGD","LU1974910355.USD","SG9999001440.SGD","LU1430594728.SGD","LU1989771016.USD","LU1066053197.SGD","LU1839511570.USD","IE00B7SZLL34.SGD","IE0002270589.USD","IE00B19Z3B42.SGD","LU0122379950.USD","LU2324357040.USD","IE00B19Z3581.USD","LU2125154935.USD","LU1066051811.HKD","SG9999015341.SGD","LU1674673691.USD","LU1934455194.USD","LU1093756168.USD","BK4534","BK4585","LU0320765992.SGD","LU2089984988.USD","LU1571399168.USD","LU2491050071.SGD","LU0238689110.USD","LU2361044865.SGD","BK4533","LU0208291251.USD","LU0289739699.SGD","LU1057294990.SGD","LU1923622614.USD","IE00B1BXHZ80.USD","LU2361045086.USD","LU2125154778.USD","BK4532","LU1983299246.USD","LU0098860793.USD","BK4568","LU2360032135.SGD","IE00BJJMRZ35.SGD","IE0002141913.USD","LU0965509010.AUD","LU1917777945.USD","LU1699723380.USD","SG9999001176.SGD","IE00BLSP4452.SGD","LU0942090050.USD","LU0211331839.USD","LU1929549753.HKD","LU1116320901.HKD","LU0889565916.HKD","LU1023059063.AUD","MRK","IE00BBT3K403.USD","LU1037948541.HKD","LU0109394709.USD","IE00BJT1NW94.SGD","LU0130517989.USD","LU0203345920.USD","BK4559","LU0106261372.USD","LU1066051225.USD","LU2023250843.SGD","SG9999015945.SGD","IE0009355771.USD","IE00BSNM7G36.USD","SG9999014575.USD","LU1941712348.USD","LU0266013472.USD","LU0058720904.USD","IE00BLSP4239.USD","LU1778281490.HKD","LU1934455863.HKD","LU0965509283.SGD","LU1093756325.SGD","IE000M9KFDE8.USD","SG9999014559.SGD","LU0859254822.USD","BK4566","LU0234570918.USD","BK4578","LU1069347547.HKD","LU1941712264.USD","LU0006306889.USD","LU0130102774.USD","LU0965509101.SGD","SG9999014567.USD","IE00BN8TJ469.HKD","LU2461242641.AUD","LU2087621335.USD","LU2468319806.SGD","LU0868494708.USD","LU1066051498.USD","LU1291159041.SGD","LU0861579265.USD","IE00B4R5TH58.HKD","LU0203347892.USD","BK4516","IE00BFTCPJ56.SGD","LU0114720955.EUR","LU0234572021.USD","SG9999002232.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642592431","title":"Noveris Health Sciences appoints Geoff Griffiths as strategic advisor","url":"https://stock-news.laohu8.com/highlight/detail?id=2642592431","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642592431?lang=en_us&edition=fundamental","pubTime":"2026-06-09 04:06","pubTimestamp":1780949178,"startTime":"0","endTime":"0","summary":"Noveris Health Sciences appointed Geoff Griffiths as strategic advisor to support commercialization and growth initiatives.He will advise management, the board on IP strategy, commercialization, licensing, partnerships, corporate development.Griffiths is head of operations at Shackelford Pharma, advancing a neurology drug candidate toward Phase 2 readiness.He also leads G3 Strategic Consulting; previously held leadership roles at Mylan Pharmaceuticals, Abbott Laboratories in commercialization, market access, biosimilars.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260608:nNDL4L7gJG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4533","IE00B2B36J28.USD","LU1023059063.AUD","SG9999002232.USD","LU0868494617.USD","SGXZ41872573.SGD","BK4504","LU0266013472.USD","BK4007","LU1989763427.SGD","LU0114720955.EUR","LU2112291526.USD","BK4588","BK4583","LU0122379950.USD","BK4585","SG9999004303.SGD","IE00BJJMRZ35.SGD","BK4568","LU1989763690.USD","BK4082","IE0002141913.USD","LU1691799644.USD","LU0289739699.SGD","LU1914381329.SGD","LU2324357040.USD","LU0170899867.USD","LU1057294990.SGD","LU1721429741.USD","LU2089984988.USD","LU2133065610.SGD","LU0234572021.USD","IE0009355771.USD","IE00BJT1NW94.SGD","VTRS","SG9999002224.SGD","BK4581","IE00BFTCPJ56.SGD","BK4592","ABT","LU0882574055.USD","LU1721429402.USD","LU2468319806.SGD","LU0058720904.USD","SGXZ23171101.USD","LU2211815571.USD","LU2237957811.SGD","LU1061106388.HKD","LU1839511570.USD","LU2237957902.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641388034","title":"Gilead Sciences Faces Potential Threat From In Vivo CAR-T, RBC Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2641388034","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641388034?lang=en_us&edition=fundamental","pubTime":"2026-06-08 23:00","pubTimestamp":1780930803,"startTime":"0","endTime":"0","summary":"Gilead Sciences (GILD) faces a potential threat from in vivo CAR-T, an early-stage technology that could transform the cell therapy space and impact 10% to 15% of Gilead's future revenue, RBC Capital ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00BSNM7G36.USD","SG9999015945.SGD","LU1585245621.USD","LU0320765992.SGD","LU0965509283.SGD","GILD","LU2087621335.USD","LU2089984988.USD","BK4550","LU0965509101.SGD","LU0861579265.USD","IE00B3T34201.USD","IE0002270589.USD","LU0882574055.USD","LU0965509010.AUD","BK4583","BK4588","LU1037948897.HKD","BK4566","LU1037948541.HKD","LU1674673428.USD","LU2468319806.SGD","LU1061106388.HKD","LU0965508806.USD","IE00B19Z3581.USD","LU0889565916.HKD","BK4532","LU1674673691.USD","LU1778281490.HKD","BK4230","LU1934455277.USD","LU1057294990.SGD","LU0114720955.EUR","BK4568","LU1934455863.HKD","LU1839511570.USD","LU0109394709.USD","LU0234570918.USD","LU1430594728.SGD","IE00B19Z3B42.SGD","IE00BZ1G4Q59.USD","LU0058720904.USD","BK4139","CAR","LU1066053197.SGD","LU1571399168.USD","LU1934455194.USD","SG9999015952.SGD","LU0289739699.SGD","LU1066051498.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641484830","title":"Tonix Pharmaceuticals Enters Second Commercial Payer Deal, Expands Drug Coverage","url":"https://stock-news.laohu8.com/highlight/detail?id=2641484830","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641484830?lang=en_us&edition=fundamental","pubTime":"2026-06-08 20:24","pubTimestamp":1780921462,"startTime":"0","endTime":"0","summary":"Tonix Pharmaceuticals  said Monday it reached an agreement with a second major group purchasing organization to provide coverage for its sublingual tablet Tonmya for fibromyalgia.The new contract extends treatment access to approximately 17 million more commercial lives in the US, the company said.Combined with a previous contract, the drug is now covered for nearly 52 million commercial lives, and is also accessible in the majority of states through Medicaid programs encompassing roughly 75 million individuals, Tonix said.Shares of the company were up 5.6% in Monday premarket trading.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4583","BK4139","TNXP"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"compareEarnings":[{"period":"1week","weight":-0.0255},{"period":"1month","weight":0.0022},{"period":"3month","weight":0.0916},{"period":"6month","weight":0.0751},{"period":"1year","weight":0.2338},{"period":"ytd","weight":0.084}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"name":"BK4583","nameEN":"BK4583"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Monkeypox Concept(BK4583),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Monkeypox Concept(BK4583) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Monkeypox Concept,BK4583,Monkeypox Concept股票,Monkeypox Concept股票老虎,Monkeypox Concept股票老虎国际,Monkeypox Concept行情,Monkeypox Concept股票行情,Monkeypox Concept股价,Monkeypox Concept股市,Monkeypox Concept股票价格,Monkeypox Concept股票交易,Monkeypox Concept股票购买,Monkeypox Concept股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Monkeypox Concept(BK4583),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Monkeypox Concept(BK4583) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}